InfuSystem Inks Distribution Pact For Solo-Dex's Continuous Peripheral Nerve Block Catheters

InfuSystem Holdings Inc INFU has announced a national distribution agreement with Solo-Dex Inc for its proprietary continuous nerve block catheters.

  • With Solo-Dex catheter over the needle technology, all anesthesiologists can place facile continuous peripheral block catheter in two to three minutes for common procedures such as shoulder repair, hip & knee replacement, and general surgical procedures. 
  • Once placed, Solo-Dex products are designed to continuously introduce acute pain management medication's type, quantity, and volume for days.
  • Continuous regional anesthesia coupled with mild sedation may eliminate the need for a patient to receive general anesthesia, which requires manipulating the airway, disrupting the patient's cognition, and extending recovery. 
  • Price Action: INFU shares are up 5.18% at $10.77 during the market session on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsHealth CareContractsMoversTrading IdeasGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!